Association of the British Pharmaceutical Industry (ABPI)
Industry responds to the government’s technical notices published in case of a ‘no-deal’ Brexit
Following a speech from the secretary of state, Dominic Raab, on the steps that government as well as business and the public sector should be taking in case of a ‘no-deal’ scenario for Brexit, we take a look at some of the responses from industry… more
From molecule to medicine, the importance of persistence
Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. more
The top five tweets: From OBN Awards to biologics — what did EPM readers enjoy this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more
Top ten most important medicines in NHS history listed in new report
A new report from the Office of Health Economics (OHE) — commissioned by the Association of the British Pharmaceutical Industry (ABPI) — has revealed what health leaders believe to be the ten most important medicines in NHS history. more
ABPI responds to MHRA recent guidance on Brexit implementation
The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. more
The top five tweets: From innovation arms race to smallpox — what enlightened EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more
ABPI and BIA respond to government white paper on post-Brexit relationship with EU
A joint statement from the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) has been released in response to the publication of a government white paper more
ABPI responds to NHS England boss’ comments on Brexit preparations
The Association of the British Pharmaceutical Industry has issued a response to comments made by Simon Stevens — chief executive of NHS England — during his interview on the Andrew Marr show earlier this month. more
ABPI data shows significant commitment of pharma industry to UK
Data published by the Association of the British Pharmaceutical Industry (ABPI) on Disclosure UK has revealed significant investment into R&D. more
The top five tweets: From industry insights to plasma manufacturing — what did EPM readers enjoy this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more
Insights into the histories of the ABPI & NHS and what the future holds
Revealing her insights, Dr Sheuli Porkess, deputy chief scientific officer of the Association of the British Pharmaceutical Industry (ABPI), has recently discussed celebrating 70 years of the NHS and the ABPI, how both have been working to advance me more
Pharma industry apprenticeships at a four-year high, according to ABPI survey
Higher level apprenticeships have hit a four-year high across the pharmaceutical industry, according to a new survey into links between industry and academia by the Association of the British Pharmaceutical Industry (ABPI). more
Thought piece — ABPI highlights the increasing role of the UK in fighting global AMR
The Association of the British Pharmaceutical Industry (ABPI) has released a thought piece looking at the UK’s increasing role in the fight against antimicrobial resistance (AMR). more
Industry agrees with latest government report on impact of Brexit on pharma sector
The life sciences sector responds favourably to the report by the Business, Energy and Industrial Strategy (BEIS) Committee stating the importance of securing a post-Brexit deal to protect the pharma industry. more
ABPI reveals virtual reality experience looking at the future of medical science
The Association of the British Pharmaceutical Industry (ABPI) delves into the futuristic realm of medicine, with advances that rival those thought out in science fiction, in its new virtual reality experience. more
British public willing to help the NHS advance medical research, notes YouGov poll
A new poll from YouGov has revealed that the majority of the British public will personally step up to help the NHS advance medical research and fight diseases of the future. more
Race against time: Looking at the latest Brexit developments and their impact on pharma
With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more
The top five tweets: From the ‘secret payments’ to asthma — what interested EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more
ABPI responds to the investigation by The Times into ‘secret payments’ by pharma companies
The ABPI has responded to an investigation performed by The Times into ‘secret payments’ worth millions made by two major pharma companies to healthcare professionals (HCPs) and organisations (HCOs) more
Cautious optimism on Brexit progression: Pharma, biotech & manufacturing industries give their thoughts
As the guidelines for the negotiations of future relations between the EU and the UK are approved, allowing the progression of Brexit talks, pharma, biotech and manufacturing industry leaders give their opinions on the transition. more
